Photo

Reuters Photojournalism

Our day's top images, in-depth photo essays and offbeat slices of life. See the best of Reuters photography.  See more | Photo caption 

Photo

Rage in Brazil

Mass protests erupt in the biggest cities of Brazil.  Slideshow 

Photo

The Afghan Army

The many faces of the Afghan National Army, which has taken over security of the country from NATO.  Slideshow 

Sponsored Links

NYC offers discount card for prescription drugs

Related Topics

NEW YORK | Thu May 19, 2011 10:34am EDT

NEW YORK (Reuters) - New York City began offering a new card on Wednesday that lets people buy prescription drugs at big discounts, a step that could potentially increase drug sales and ease strains on the city's public hospitals.

Residents, tourists, commuters, and people who already have insurance, are all eligible for the new and free BigAppleRx cards, regardless of age, income, or citizenship, Mayor Michael Bloomberg told reporters.

Discounts are expected to average 47 percent. Patients with diabetes could save as much as $831 a year on generic medicines while asthma sufferers could save $667 on inhaler drugs.

Some localities are years ahead of New York City in offering discount drug cards. Neighboring Nassau County, for example, says its program began in 2004 and it saves residents 24 percent off most retail prescriptions and up to 50 percent on generic drugs.

Many pharmacies around the nation offer similar discount cards; HealthTrans Access, which will run the city's program, has already signed up 10.6 million people around the country.

About 2,000 drugstores in New York City -- 85 percent of the total -- are willing to offer the discounts in return for attracting more business from shoppers who also might buy other items while in the stores, Bloomberg said.

Last year, more than 800,000 New Yorkers said they did not fill a prescription because they could not pay for it, said Deputy Mayor Linda Gibbs. Even New Yorkers who have health insurance may have plans that do not cover drugs.

If the new cards enable these individuals to afford the prescription drugs they need, they might be able to avoid seeking emergency treatment at one of the city's 11 public hospitals, a mayoral aide said.

New York City has one of the nation's biggest Medicaid programs, whose recipients already get the benefit of lower drug prices. Still, the city's public hospitals treat 450,000 people a year who lack insurance, said a spokeswoman for the hospital agency, the Health & Hospitals Corporation.

"A lot of our patients can get medication for $2," she said. "But not all New Yorkers come to the Health and Hospitals Corporation; that's the benefit of this card."

For years, the finances of the Health & Hospitals Corporation have been under pressure, and its closing cash balance is expected to fall to $31 million in 2015 from $832 million in 2011, according to a fiscal watchdog.

The list of drug chains that will accept the new cards includes Target. The discount cards can be downloaded at www.bigapplerx.com or obtained by calling 311, the city's help line.

We welcome comments that advance the story through relevant opinion, anecdotes, links and data. If you see a comment that you believe is irrelevant or inappropriate, you can flag it to our editors by using the report abuse links. Views expressed in the comments do not represent those of Reuters. For more information on our comment policy, see http://blogs.reuters.com/fulldisclosure/2010/09/27/toward-a-more-thoughtful-conversation-on-stories/
Comments (1)
BillJenner wrote:
It’s good to see a state acknowledging that by taking on some expenses to get people their medications, you are saving both money and human life by reducing ED visits in the future. I would like even better to see some kind of medication adherence education program. Half of all prescriptions in the US are either not taken or taken incorrectly which ends up costing us over $210 billion every year.

May 19, 2011 11:44am EDT  --  Report as abuse
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.